August 30, 2021
Boehringer Ingelheim to continue supply to US FMD vaccine bank
The United States Department of Agriculture has selected Boehringer Ingelheim to continue supplying antigen for a vaccine bank that protects US livestock from a potential outbreak of foot-and-mouth disease (FMD).
The company will build on work it has done since receiving a contract in 2020 to supply the National Animal Vaccine and Veterinary Countermeasures Bank.
Since receiving the contract, Boehringer Ingelheim has been supplying doses of FMD vaccine antigen concentrate to the bank, a strategic reserve of frozen vaccine antigen concentrate that the company could quickly formulate into completed vaccine in the event of a disease outbreak.
Boehringer Ingelheim could quickly supply those doses to US livestock producers in an FMD outbreak.
"As a company dedicated to the well-being of animals and people, we are honored to help protect US livestock from an outbreak that would have devastating consequences," Steve Boren, vice president of Boehringer Ingelheim's US livestock business, said.
The last FMD outbreak in the US happened in 1929, but veterinarians, livestock producers and industry groups have long warned about the possibility that globalisation and international travel could bring the disease into the the country from parts of the world where it continues to affect animals.
- Boehringer Ingelheim